5/9/2025

Stryker's Mako spine and shoulder applications are set to launch soon, potentially boosting its orthopedics and spine businesses. Click to read why SYK is a Hold.

Source: SeekingAlpha

5/9/2025

We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at where Stryker Corporation (NYSE:SYK) stands against other best medical device stocks to buy now. Trump’s Tariffs Are Dividing the Medical Community On April 16, CNBC reported that Trump’s tariffs are […]

Source: Yahoo

5/8/2025

Stryker (NYSE:SYK) recently affirmed its commitment to shareholder value by declaring a quarterly dividend of $0.84 per share, maintaining consistency with its focus on strong dividend growth. Over the last month, Stryker's shares appreciated 11% amid broader market gains following the announcement of a U.S.-U.K. trade deal, which lifted investor sentiment. Although Stryker's net income and earnings per share declined, the positive market environment and the company's proactive move to raise...

Source: Yahoo

5/8/2025

Portage, Michigan, May 08, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable July 31, 2025, to shareholders of record at the close of business on June 30, 2025, representing an increase of 5.0% versus the prior year and unchanged from the previous quarter. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer i

Source: Yahoo

5/8/2025

Stryker announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable July 31, 2025, to shareholders of record at the close of business on June 30, 2025,...

Source: Finnhub

5/8/2025

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Abbott Laboratories (NYSE:ABT) and its peers.

Source: Yahoo

5/7/2025

Stryker Corp. stock outperforms competitors on strong trading day

Source: MarketWatch

5/7/2025

Key Insights Stryker's estimated fair value is US$348 based on 2 Stage Free Cash Flow to Equity Stryker's US$378 share...

Source: Yahoo

5/7/2025

For Q1 2025, the Fidelity Select Health Care Portfolio returned -1.03%, underperforming the MSCI health care index. Click here to read the full commentary.

Source: SeekingAlpha

5/7/2025

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including Neogen (NASDAQ:NEOG) and its peers.

Source: Yahoo

5/6/2025

Stryker Corp. stock outperforms competitors despite losses on the day

Source: MarketWatch

5/6/2025

Zimmer Biomet's stock drops 10% after weak Q1 results.

Source: SeekingAlpha

5/6/2025

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including Stryker (NYSE:SYK) and its peers.

Source: Yahoo

5/5/2025

Zimmer Biomet Holdings on Monday lowered its 2025 adjusted profit forecast, and said it expects the proposed trade tariffs to weigh on the company's earnings this year. The Warsaw,...

Source: Finnhub

5/5/2025

Zimmer Biomet Holdings on Monday lowered its full-year adjusted profit forecast, as the medical device maker anticipates a hit from its recent acquisition of Paragon 28, currency volatility, and...

Source: Finnhub

5/5/2025

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition.

Source: Yahoo

5/2/2025

Although the revenue and EPS for Stryker (SYK) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Source: Yahoo

5/2/2025

Stryker (NYSE:SYK) delivered mixed financial results, with first-quarter 2025 earnings showing increased sales but reduced net income and EPS compared to the previous year. The company's decision to raise its earnings guidance amid strong sales growth and demand for capital products might have bolstered investor confidence, coinciding with a 3.6% rise in its stock price over the past week. This movement aligns with broader market trends, as markets rose following a strong jobs report and...

Source: Yahoo

5/2/2025

SYK's first-quarter results reflect strong segmental performance, along with a rise in operating margin.

Source: Yahoo

5/2/2025

Stryker Corp. stock rises Friday, still underperforms market

Source: MarketWatch